Technical Evaluation: Identification of Pathogenic Mutations in PKD1 and PKD2 in Patients with Autosomal Dominant Polycystic Kidney Disease by Next-Generation Sequencing and Use of a Comprehensive New Classification System

Autor: Eiji Higashihara, Takafumi Fukui, Krisztina Rigo, Moritoshi Kinoshita, Kiyonori Katsuragi, Tim Hague, Kozo Kawahara, Nobuhisa Gondo, Masahiko Takeshi, Kimiyoshi Sudo, Takehiko Oka, Shigeo Horie, Ryo Higashiyama, Haruna Kawano, Kikuo Nutahara, Daisuke Koga
Jazyk: angličtina
Rok vydání: 2016
Předmět:
0301 basic medicine
Molecular biology
DNA Mutational Analysis
030232 urology & nephrology
Gene Identification and Analysis
Artificial Gene Amplification and Extension
Bioinformatics
urologic and male genital diseases
Polymerase Chain Reaction
Database and Informatics Methods
0302 clinical medicine
Sequencing techniques
Medicine and Health Sciences
DNA sequencing
Frameshift Mutation
Sanger sequencing
Genetics
Gene Rearrangement
Multidisciplinary
medicine.diagnostic_test
High-Throughput Nucleotide Sequencing
Nonsense Mutation
Genomics
Polycystic Kidney
Autosomal Dominant

Codon
Nonsense

symbols
Medicine
Transcriptome Analysis
Research Article
Next-Generation Sequencing
Adult
Substitution Mutation
TRPP Cation Channels
Science
Nonsense mutation
Autosomal dominant polycystic kidney disease
Mutation
Missense

Research and Analysis Methods
Sensitivity and Specificity
03 medical and health sciences
symbols.namesake
Genomic Medicine
medicine
Humans
Genetic Testing
Allele
Mutation Detection
Genetic testing
Clinical Genetics
PKD1
business.industry
Genetic heterogeneity
Biology and Life Sciences
Computational Biology
Reproducibility of Results
Human Genetics
Gene rearrangement
medicine.disease
Genome Analysis
030104 developmental biology
Biological Databases
Molecular biology techniques
Mutation
Mutation Databases
RNA Splice Sites
business
Multiplex Polymerase Chain Reaction
Zdroj: PLoS ONE
PLoS ONE, Vol 11, Iss 11, p e0166288 (2016)
ISSN: 1932-6203
Popis: Genetic testing of PKD1 and PKD2 is expected to play an increasingly important role in determining allelic influences in autosomal dominant polycystic kidney disease (ADPKD) in the near future. However, to date, genetic testing is not commonly employed because it is expensive, complicated because of genetic heterogeneity, and does not easily identify pathogenic variants. In this study, we developed a genetic testing system based on next-generation sequencing (NGS), long-range polymerase chain reaction, and a new software package. The new software package integrated seven databases and provided access to five cloud-based computing systems. The database integrated 241 polymorphic nonpathogenic variants detected in 140 healthy Japanese volunteers aged >35 years, who were confirmed by ultrasonography as having no cysts in either kidney. Using this system, we identified 60 novel and 30 known pathogenic mutations in 101 Japanese patients with ADPKD, with an overall detection rate of 89.1% (90/101) [95% confidence interval (CI), 83.0%-95.2%]. The sensitivity of the system increased to 93.1% (94/101) (95% CI, 88.1%-98.0%) when combined with multiplex ligation-dependent probe amplification analysis, making it sufficient for use in a clinical setting. In 82 (87.2%) of the patients, pathogenic mutations were detected in PKD1 (95% CI, 79.0%-92.5%), whereas in 12 (12.8%) patients pathogenic mutations were detected in PKD2 (95% CI, 7.5%-21.0%); this is consistent with previously reported findings. In addition, we were able to reconfirm our pathogenic mutation identification results using Sanger sequencing. In conclusion, we developed a high-sensitivity NGS-based system and successfully employed it to identify pathogenic mutations in PKD1 and PKD2 in Japanese patients with ADPKD.
Databáze: OpenAIRE